CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 602 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00377949
NCT00377949N/ACompleted
CompareCT.gov

The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension

Georgetown University·observational·Posted Sep 19, 2006·Updated May 3, 2016

In Brief

An observational study for Systemic Sclerosis and 3 related conditions. Completed, enrolled 602 participants across 25 sites.

Detailed Summary

The purpose of this study is to determine the timeline of progression from pre-pulmonary hypertension to diagnosable pulmonary hypertension based on right heart catheterization. Moreover, to determine the timeline for progression from diagnosable pulmonary hypertension to clinical worsening of disease as defined as death, hospitalization, or worsening of PHT symptoms.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSystemic Sclerosis, Scleroderma, Pulmonary Hypertension, Pulmonary Arterial Hypertension
CountriesUnited States
CollaboratorsGilead Sciences

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 19, 2006
Enrollment StartFeb 1, 2005
Primary CompletionJan 1, 2016
TodayJul 2, 2026
Enrollment to primary: 10.9 yearsPosted 19.8 years ago